Effect of reboxetine on the pharmacokinetics of lorazepam in healthy volunteers

By Jannuzzo M.G.   Dostert P.   Strolin Benedetti M.   Bosc M.   Renoux A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 300-301

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of reboxetine in healthy volunteers with different ethnic descents

By Hendershot Pamela E.   Fleishaker Joseph C.   Lin Keh-Ming   Nuccio Inocencia D.   Poland Russell E.  

Psychopharmacology, Vol. 155, Iss. 2, 2001-05 ,pp. : 148-153

Springer Publishing Company

Access to resources Recommend Favorite

Asenapine Pharmacokinetics in Hepatic and Renal Impairment

By Peeters Pierre  

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 471-481

Adis International

Access to resources Recommend Favorite

Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin

By Boulton David W.   Li Li   Frevert Ernst U.   Tang Angela   Castaneda Lorna   Vachharajani Nimish N.   Kornhauser David M.   Patel Chirag G.  

Clinical Pharmacokinetics, Vol. 50, Iss. 4, 2011-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment

By Weil Angelika  

Clinical Pharmacokinetics, Vol. 49, Iss. 9, 2010-09 ,pp. : 607-618

Adis International

Access to resources Recommend Favorite